Multicenter lupus register from Argentina, the RELESSAR database: Influence of ethnicity on disease phenotype.


Journal

Lupus
ISSN: 1477-0962
Titre abrégé: Lupus
Pays: England
ID NLM: 9204265

Informations de publication

Date de publication:
Apr 2022
Historique:
entrez: 6 4 2022
pubmed: 7 4 2022
medline: 8 4 2022
Statut: ppublish

Résumé

The objective is to describe the main characteristics of patients with systemic lupus erythematosus (SLE) in Argentina and to examine the influence of ethnicity on the expression of the disease. RELESSAR is a multicentre register carried out by 106 researchers from 67 rheumatologic Argentine centres. It is a cross-sectional study of SLE (1982/1997 ACR) patients. RELESSAR electronic database includes demographic, cumulative SLE manifestations, SELENA-SLEDAI, SLICC-SDI, Katz's severity and Charlson's comorbidity indexes and treatment patterns. We included 1,610 patients, 91.7% were female with a median age at diagnosis of 28.1 ± 12.8; 96.2% met ≥4 ACR 1982/97 criteria. Frequent manifestations were arthritis (83.5%), malar rash (79.5%), photosensitivity (75.3%), haematological (63.8%) and renal disease (47.4%), antinuclear antibodies (96%), anti-dsDNA (66.5%) and anti-Smith antibodies (29%). The mean Selena-SLEDAI score at last visit was 3.18 (SD 4.3) and mean SDI was 1 (SD 1.3). The accumulated treatments most frequently used were antimalarials (90.4%), corticosteroids (90%), azathioprine (31.8%), intravenous cyclophosphamide (30.2%), mycophenolate mofetil or mycophenolic acid (24.5%), methotrexate (19.3%), belimumab 5.3% and rituximab 5.1%. Refractory lupus was diagnosed in 9.3% of the cases. The main causes of death were lupus activity (25.0%), activity and concomitant infections (25.0%), infections (18.2%), vascular disease (13.6%) and cancer (4.5%). Mortality was associated with higher SLEDAI, Katz, damage indexes and comorbidities. Of the 1610 patients included, 44.6% were Caucasian, 44.5% Mestizo, 8.1% Amerindian and 1.2% Afro-Latin American. Mestizo patients had higher male representation, low socioeconomic status, more inadequate medical coverage, fewer formal years of education and shorter disease duration. Polyadenopathies and Raynaud's phenomenon were more frequent in Caucasians. In the logistic regression analysis higher damage index (OR 1.28, CI 95% 1.02-1.61, This study represents the largest number of adult patients with SLE studied in Argentina. Caucasian patients were differentiated by having Raynaud's phenomenon and polyadenopathy more frequently, while patients of Mestizo origin had higher damage indexes.

Identifiants

pubmed: 35382633
doi: 10.1177/09612033221083267
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

637-645

Auteurs

Mercedes A García (MA)

198367HIGA General San Martin, La Plata, Argentina.

Paula Alba (P)

Hospital Córdoba, Córdoba, Argentina.

Victor Del Campo-Perez (V)

Servicio de Medicina Preventiva y Epidemiología, 96682Complexo Hospitalario Universitario de Vigo, Vigo, España.

Susana Roverano (S)

Hospital J.M. Cullen, Santa Fe, Argentina.

Rosana M Quintana (RM)

Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Rosario, Argentina.

Analia P Alvarez (AP)

Hospital Penna603552, Buenos Aires, Argentina.

Cesar E Graf (CE)

Centro Médico Mitre, Paraná, Argentina.

Cecilia Pisoni (C)

CEMIC62883, Buenos Aires, Argentina.

Alberto Spindler (A)

Centro de Investigaciones Médicas Tucumán, Tucumán, Argentina.

Catalina Gomez (C)

Hospital Central de Formosa, Formosa, Argentina.

Heber M Figueredo (HM)

Hospital de Alta Complejidad Pte. Juan Domingo Perón, Formosa, Argentina.

Silvia Papasidero (S)

Hospital General de Agudos Dr. Enrique Tornú580023, Buenos Aires, Argentina.

Raul Paniego (R)

CePReR, Santa Rosa, Argentina.

Maria C de la Vega (MC)

CEIM Investigaciones Médicas, Buenos Aires, Argentina.

Emma Civit (E)

Hospital del Carmen, Godoy Cruz, Argentina.

Luciana Gonzalez Lucero (L)

Hospital Angel C. Padilla, Tucumán, Argentina.

Maria V Martire (MV)

Hospital Italiano de La Plata, La Plata, Argentina.

Rodrigo Aguila Maldonado (R)

198367HIGA General San Martin, La Plata, Argentina.

Sergio Gordon (S)

HIGA Dr. Alende, Mar del Plata, Argentina.

Carla Gobbi (C)

Sanatorio Allende, Cordoba, Argentina.

Marina Micelli (M)

541318Hospital General de Agudos José María Ramos Mejía, Buenos Aires, Argentina.

Romina Nieto (R)

Hospital Provincial de Rosario, Rosario, Argentina.

Gretel Rausch (G)

Consultorio Privado, Rio Grande, Argentina.

Vanina Gongora (V)

Hospital San Martin, Parana, Argentina.

Agustina Damico (A)

Hospital Interzonal Dr. José Penna, Bahía Blanca, Argentina.

Diana Dubinsky (D)

Hospital Clínicas, Buenos Aires, Argentina.

Alberto Orden (A)

Hospital Aeronáutico Central, 433287 Buenos Aires, Argentina.

Johana Zacariaz (J)

Hospital Italiano de Buenos Aires, 37533 Buenos Aires, Argentina.

Julia Romero (J)

Clínica Alvear San Juan, San Juan, Argentina.

Mariana Pera (M)

198367HIGA General San Martin, La Plata, Argentina.

Mario Goñi (M)

Centro de Especialidades Médicas Ambulatorias de Rosario, Rosario, Argentina.

Oscar Rillo (O)

58783Hospital General de Agudos Dr Ignacio Pirovano, Buenos Aires, Argentina.

Roberto Baez (R)

Hospital De General Roca, General Roca, Argentina.

Valeria Arturi (V)

198367HIGA General San Martin, La Plata, Argentina.

Andrea Gonzalez (A)

Hospital Eva Perón, San Martín, Argentina.

Florencia Vivero (F)

Hospital Privado de la Comunidad, Mar del Plata, Argentina.

Maria E Bedoya (ME)

Hospital San Martin, Paraná, Argentina.

Maria M Shmid (MM)

Hospital Angela Iglesia de Llano, Corrientes, Argentina.

Victor Caputo (V)

Sanatorio Juncal, Temperley, Argentina.

Maria S Larroude (MS)

Consultorio Privado, Avellaneda, Argentina.

Nadia Dominguez (N)

541318Hospital General de Agudos José María Ramos Mejía, Buenos Aires, Argentina.

Graciela N Gómez (GN)

Instituto de Investigaciones Médicas Alfredo Lanari, 207909 Buenos Aires, Argentina.

Graciela N Rodriguez (GN)

198367HIGA General San Martin, La Plata, Argentina.

Josefina Marin (J)

Hospital Italiano de Buenos Aires, 37533 Buenos Aires, Argentina.

Victoria Collado (V)

Instituto de Investigaciones Médicas Alfredo Lanari, 207909 Buenos Aires, Argentina.

Marisa Jorfen (M)

Centro de Especialidades Médicas Ambulatorias, Rosario, Argentina.

Zaida Bedran (Z)

Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina.

Ana Curti (A)

Hospital Luis Carlos Lagomaggiore, 297830 Mendoza, Argentina.

Maria V Gazzoni (MV)

Hospital Nacional de Clinicas, 63049 Córdoba, Argentina.

Judith Sarano (J)

Instituto de Investigaciones Médicas Alfredo Lanari, 207909 Buenos Aires, Argentina.

Marcos Zelaya (M)

541318Hospital General de Agudos José María Ramos Mejía, Buenos Aires, Argentina.

Monica Sacnun (M)

Hospital Provincial del Centenario, 541448 Rosario, Argentina.

Pablo Finucci Curi (P)

Hospital San Martin, Parana, Argentina.

Romina Rojas Tessel (R)

218812Hospital Señor del Milagro, Salta, Argentina.

Maira Arias Saavedra (M)

541318Hospital General de Agudos José María Ramos Mejía, Buenos Aires, Argentina.

Maria E Sattler (ME)

Hospital Escuela Eva Peron, Granadero Baigorria, Argentina.

Maximiliano A Machado Escobar (MA)

Hospital Eva Perón, Tucumán, Argentina.

Pablo Astesana (P)

Sanatorio Allende, Cordoba, Argentina.

Ursula Paris (U)

Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina.

Belen Maria Virasoro (BM)

CEMIC62883, Buenos Aires, Argentina.

Maria J Santa Cruz (MJ)

Hospital General de Agudos Dr. Enrique Tornú580023, Buenos Aires, Argentina.

Alberto Allievi (A)

28213Universidad del Salvador, Autoinmunidad, Buenos Aires, Argentina.

Juan M Vandale (JM)

Hospital Privado de la Comunidad, Mar del Plata, Argentina.

Noelia G Hojberg (NG)

541318Hospital General de Agudos José María Ramos Mejía, Buenos Aires, Argentina.

Bernardo Pons-Estel (B)

198365Sanatorio Parque, Rosario, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH